Unichem Laboratories is recalling around 96.8 thousand bottles of Bisoprolol Fumarate tablets used for treatment of hypertension, from the US market, latest Enforcement Report of the US health regulator has said.
Unichem Pharmaceuticals USA Inc is recalling 96,876 bottles of Bisoprolol Fumarate tablets in the strength of 5 mg manufactured by Unichem Laboratories at its Goa plant, USFDA said in its Enforcement Report.
The reason for the recall is "Failed Impurities/ Degradation specifications: out of specification for an unknown impurity was observed during the 18-month stability testing," it added.
Also Read
The voluntary ongoing nationwide recall is a class II recall, the report said.
As per the USFDA, a class II recall is initiated in a "situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote".
Unichem Pharmaceuticals USA, Inc is a wholly-owned subsidiary of Unichem Laboratories.
Disclaimer: No Business Standard Journalist was involved in creation of this content
